Stay updated on Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Sign up to get notified when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.

Latest updates to the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4. This indicates a small, non-content-changing update to the document metadata.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded the NIH grant number R01CA219960 and two new study-record dates (2026-04-20 and 2026-05-04) to the study record, and removed older identifiers (NCI-2017-00113 and MC1685) as well as earlier dates (2025-05-15 and 2025-05-16). These edits update funding attribution and internal registry references used for record-keeping.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page’s displayed platform revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded two MeSH terms—B-cell chronic lymphocytic leukemia and Malignant lymphoma, large B-cell, diffuse—to the Additional Relevant MeSH Terms.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision added: v3.5.0. Revision removed: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.